Close Menu

NEW YORK (GenomeWeb) – NovellusDx announced today that it has raised $6 million in equity financing.

Helsinn Investment Fund SA SICAR, BioCapital Impact Fund, and Windham Venture Partners all participated in the funding round. The company said it had also previously raised nearly $17 million.

In a statement, NovellusDx CEO Haim Gil-Ad said the funding will allow the firm to commercialize and support continuing development and improvement of its next-generation sequencing technology.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A genetic genealogy analysis helped secure the release of a California man from prison after getting his murder conviction overturned, the Guardian reports.

Technology Review discusses the concerns that come along with the ability to quickly synthesize viruses like SARS-CoV-2.

Researchers have uncovered large bacteriophages whose genomes include translational machinery, Live Science reports.

In PNAS this week: role for Myc in alternative splicing regulation in prostate cancer, variation in methylation in Arabidopsis, and more.